A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.
Clinical trial NCT05967689 · RECRUITING
Trial details
- NCT number
- NCT05967689
- Sponsor
- Taiho Oncology, Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-31
- Primary completion
- 2028-08-31
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.